Search

everythinglearnresearchcommunity

for

Search:↓

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

PMC shows promise as a treatment for hair loss.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Polonium poisoning is diagnosed by detecting it in urine and feces, and treated with supportive care, infection prevention, and chelation therapy.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Traditional Persian medicine helped a woman with resistant hyperthyroidism improve and stabilize her condition.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Mogamulizumab can cause hair loss and skin rashes.

New drug shows promise for better hair growth in baldness treatment.

Strontium ranelate is no longer available for treatment.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Nail loss may be a side effect of the MS drug teriflunomide.